In this study, the expression levels of BCAAs and BCAT2 in PCa samples and cell lines were evaluated, and the correlation between BCAT2 expression and clinicopathological parameters, as well as survival outcomes, of PCa patients was further investigated. Here, BCAT2 is linked to posterior cortical atrophy.